1 results match your criteria: "Center for Research in Medical Pharmacology University of Insubria Varese Italy.[Affiliation]"
Article Synopsis
- Parkinson's disease (PD) impacts 7-10 million people globally, with no existing treatments to halt or slow down its progression, largely due to a lack of understanding about how dopaminergic neuron death occurs.
- Current treatments mainly aim to compensate for dopamine deficiency in the brain but don't adequately address the underlying disease mechanisms.
- Recent research highlights the immune system's role in PD, suggesting that targeting immune pathways could improve treatment outcomes alongside existing dopaminergic therapies.